CytoDyn Inc (CYDY) Stock Unable To Sustain At Higher Level: Here is Why

After having gone through a pretty rough week, the CytoDyn Inc (OTCMKTS:CYDY) stock...

Stay Ahead of the
Stock Market Game!
Subscribe to Small Cap
Exclusive for more


Here is Who Picked Incyte Corp (NASDAQ:INCY) Shares
Guess Who Picked Up Perrigo Co Plc. (NYSE:PRGO) Shares
Here's Who Just Picked Up Rti Surgical Inc. (NASDAQ:...

After having gone through a pretty rough week, the CytoDyn Inc (OTCMKTS:CYDY) stock managed to make a bit of a recovery on Friday. Last Friday, the stock went up by 7%, however, that was not enough to save the CytoDyn stock from recording a 10% loss for the week.

This morning investors might be interested in the fortunes of the CytoDyn stock and hence, it might be a good move to track it. There was no much news about the company last week but in this context, it might be a good move to take a look at development from earlier on this month. This relates to the five-day proceedings that took place between ProstaGen and CytoDyn, which was related to 3.1 million CytoDyn shares that were held in escrow for some indemnities.

However, in relation to this situation, it was announced earlier in the month that a direct financial obligation had been created that is going to stay off the CytoDyn balance sheet.

Back on June 21, the company had also made a key announcement with regards to its product leronlimab, which has the potential of treating multiple conditions. CytoDyn revealed the preliminary results after it managed to unblind the necessary data from the clinical trial related to the treatment of COVID 19 patients. During the course of the trial, the efficacy and safety of the product were being ascertained. The publication of these results proved to be another considerable boost to the company.

Stay in the lopp :

Here's Who Just Picked Up Equity One Inc. (NY...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Equity One Inc. (NYSE:EQY) reported that Blackrock Inc. has picked

The share price of TEMPUS APPLIED SOLUTION HOLDINGS (OTCMKTS:TMPS) has soared over the last 5 days from a low of

Illumina (NASDAQ:ILMN): How Should You Trade ...

related post

Skip to content